FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: cytori

Sort
E.g., 2013-05-22
E.g., 2013-05-22
Enter a comma separated list of user names.

Five Regenerative Medicine Companies Worthy of Portfolio Addition
Posted by OTC Showcase on November 8th, 2012

Read More
comment 0
Share
Tags:
regenerative medicine, stem cell stocks, biotechnology investing, Athersys, Pluristem, Aastrom, cytori, Osiris, regenerative medicine stocks

SHOO, CLNO, PAET, CYTX Stock Market Update from PennyOtcStock
Posted by Steve Stock on October 23rd, 2011
Read More
comment 0
Share
Tags:
clean energy, cytori, NASDAQ:SHOO, NASDAQ:CYTX, Cleantech Transit, Phoenix Energy, Merced project, biomass energy, PAETEC, NASDAQ:PAET, public transportation sector, Steven

PRAN (Video Update), CLNO, CRWE, INSW, CYTX, BIOS - Market Update From DrStockPick.com!
Posted by drstockpick on March 23rd, 2011
Read More
comment 0
Share
Tags:
advertising, cytori, Crown Equity Holdings, CRWE.OB, otc:crwe, digital advertising, digital media, market awareness, online advertising, online publishing, BioScrip, Nasdaq:BIOS, renewable resources, NASDAQ:CYTX, InsWeb, NASDAQ:INSW, Cleantech Transit, CLNO, CLNO.OB, Phoenix Energy, public transportation, mass transit

Source CRWESelect : CYTX, CYPB, DMED, - Cytori Therapeutics, Cypress Bioscience and D Medical Industries Stocks!

Posted by CRWESelect Stoc... on December 16th, 2010

Cytori Therapeutics, Inc. (NASDAQ:CYTX) reported that they have entered into a strategic equity agreement to evaluate the potential of adipose derived stem and regenerative cells for the treatment of serious illnesses for which there is no fundamental treatment.

Read More
comment 0
Share
Tags:
cytori, medicines, medical technologies, NASDAQ:DMED, D Medical, Cypress, medicine services, NASDAQ:CYPB, NASDAQ:CYTX

Cytori Therapeutics (CYTX) Announces Publication of Cardiovascular Preclinical Study
Posted by QualityStocks.net on May 29th, 2009

Cytori Therapeutics announced before the opening bell that the first preclinical study to demonstrate adipose-derived stem and regenerative cells (ADRCs) significantly improved cardiac function after a heart attack has been published. This preclinical study was reported online ahead of print in the International Journal of Cardiology.

Read More
comment 0
Share
Tags:
stem cell, heart, attack, cytori, tulane

ADVERTISE WITH US